Myrtelle to Present Clinical Data and Regulatory Progress for MYR-101 Gene Therapy Program at ASGCT 2026
NEW YORK, May 11, 2026 /PRNewswire/ — Myrtelle, Inc., a clinical-stage gene therapy company selected by the FDA…
Browsing Tag